Annovis Bio Inc.

Contributing Author

Recent Articles by Annovis Bio Inc.

Nov-06	Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer's Program ANVS GlobeNewswire
Oct-27	Annovis Announces $3.4 Million Registered Direct Offering of Common Stock Priced At-the-Market under the NYSE Rules ANVS GlobeNewswire
Oct-15	Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock ANVS GlobeNewswire
Oct-10	Annovis Announces $6 Million Registered Direct Offering of Common Stock ANVS GlobeNewswire
Oct-09	Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment ANVS GlobeNewswire
Sep-25	Annovis Appoints Mark Guerin as Chief Financial Officer ANVS GlobeNewswire
Sep-16	Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap ANVS GlobeNewswire
Sep-02	Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference ANVS GlobeNewswire
Aug-12	Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results ANVS GlobeNewswire
Aug-07	Annovis Completes Full Patent Transfer to Crystal Buntanetap ANVS GlobeNewswire
Jun-26	Annovis to Attend the AAIC 2025 with Four Poster Presentations ANVS GlobeNewswire
Jun-19	Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance ANVS GlobeNewswire
Jun-05	Annovis to Host Webinar and Live Q&A on June 24, 2025 ANVS GlobeNewswire
May-13	Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results ANVS GlobeNewswire